The HSF1 Knockout TE1 Polyclonal Cells product consists of a CRISPR/Cas9-edited polyclonal knockout cell population derived from the TE1 human esophageal squamous cell carcinoma cell line, featuring targeted disruption of the HSF1 gene. This polyclonal knockout model provides a loss-of-function system for investigating HSF1-dependent processes without the isolation of single-cell clones. The heterogeneous knockout population enables robust, scalable experiments while maintaining genetic diversity that may reveal population-level responses to HSF1 ablation.
TE1 cells are an established epithelial cell line originating from a human esophageal squamous cell carcinoma, widely employed in cancer biology and drug discovery research. These cells retain key characteristics of esophageal squamous cell carcinoma, including relevant oncogenic signaling networks and stress-response mechanisms. The TE1 background is particularly valuable for studying tumor biology in the context of esophageal malignancies, where HSF1 plays a pivotal role.
HSF1 functions as the master transcriptional regulator of the heat shock response, orchestrating the expression of molecular chaperones such as HSP70, HSP90, and HSP27 to preserve proteostasis under stress. Mechanistically, HSF1 is activated by heat shock, oxidative stress, and oncogenic signals via kinases including mTOR, PLK1, AKT, and GSK3??, while SIRT1 provides negative regulation. Active HSF1 trimerizes, binds to heat shock elements, and promotes transcription of target genes including BCL2 and EGFR. HSF1 interacts with co-chaperones such as HSP90 and HSBP1, and forms complexes with BAG3, linking it to the unfolded protein response and apoptosis modulation. Through these interactions, HSF1 integrates stress signals with pro-survival and oncogenic transcriptional programs.
In esophageal squamous cell carcinoma, HSF1 is known to drive a transcriptional program that supports malignant growth, resistance to apoptosis, and adaptation to the tumor microenvironment. Disruption of HSF1 in TE1 cells abrogates this oncogenic support, making the polyclonal knockout population a powerful tool for dissecting HSF1-dependent mechanisms in esophageal cancer. This model enables investigation of how loss of HSF1 impacts cellular stress responses, proteostasis networks, and sensitivity to chemotherapeutic agents. Furthermore, it provides a platform to study crosstalk between HSF1 and pathways such as mTOR and MAPK signaling in the context of esophageal squamous cell carcinoma.
Researchers can employ HSF1 Knockout TE1 Polyclonal Cells in diverse assays including western blotting, RT-qPCR, ChIP-qPCR, heat shock viability, apoptosis, RNA-seq, and reporter gene assays to study stress response, proteostasis, and oncogenesis. These cells facilitate investigation of drug resistance and HSF1-dependent transcriptional programs in esophageal squamous cell carcinoma. For further details, contact Ascent Research.
